3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Endometrial Neoplasms
4
Lymphedema
3
Neoplasms
2
Melanoma
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Suspected Central Nervous System Tumors
1
Stomach Neoplasms
1
Skull Base Neoplasms
1
Pediatric Patients With Solid Tumors
1
Mixed Tumor, Mesodermal
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Diseases
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholecystitis
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Paclitaxel
22
Carboplatin
18
liposomal doxorubicin
14
Bevacizumab
9
Topotecan
8
Docetaxel
8
Gemcitabine
7
Cisplatin
7
rucaparib
6
pembrolizumab
6
mirvetuximab soravtansine
5
Cyclophosphamide
5
Taxes
4
Albumin-Bound Paclitaxel
4
sargramostim
3
ixabepilone
3
Cytoreduction Surgical Procedures
3
CCV-AV protocol
3
130-nm albumin-bound paclitaxel
3
taxane
2
talazoparib
2
pazopanib
2
olaparib
2
fludarabine phosphate
2
fludarabine
2
denileukin diftitox
2
cediranib
2
catumaxomab
2
belinostat
2
avelumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Ovarian Epithelial
×
Indocyanine Green
×
Clear all
No trials found.